State epidemiologist, head of immunization out at Health Department - Tulsa World

-

OKLAHOMA CITY — Oklahoma’s state epidemiologist said she was forced out of the Oklahoma State Department of Health on Tuesday after more than 20 years of service.

Before she signed the form letter announcing her resignation from the Health Department, Kristy Bradley crossed out the phrase attesting she was leaving “without duress or coercion.”

“I have faithfully served the citizens of Oklahoma for over 22 years and no cause was provided to me today in requesting my resignation,” Bradley wrote below her signature. “Therefore, I do so under duress and in lieu of termination.”

Another form, also dated Tuesday, showed Lori Linstead, the director of the Health Department’s immunization service, refused to sign a resignation letter.



https://ift.tt/2FMRAtT

Comments

Post a Comment

Popular posts from this blog

Robert F. Kennedy Jr., Soon to Announce White House Run, Sows ...

-
Image
standard childhood vaccines :: Article Creator The Vaccines You Need To Know About Before You Travel CNN  —  Few things can ruin a vacation faster than illness. But while a mild stomach bug will probably affect most travelers at some point, there are far more dangerous diseases – including potentially lethal ones – adventurers should know how to protect themselves against. Global concern is mounting over the spread of mpox, a viral illness formerly known as monkeypox, that initially killed 1 in 10 people who contracted it, but now kills up to 3.3%. In August, Sweden became the first country outside the African continent to confirm a case of the newer and more severe mpox strain, clade Ib, which has now also spread to Asia, with a confirmed case in Thailand and suspected cases in Pakistan and the Philippines. The World Health Organization (WHO) has declared the ongoing mpox outbreak across more than a dozen central African nations a ...
Read more

Meningococcal Vaccine: Protection, Risk, Schedule

-
Image
eu astrazeneca :: Article Creator Astellas Claims EU Okay For First Claudin 18.2 Cancer Drug News European Commission The EU has followed Japan and GB in approving Astellas' first-to-market claudin 18.2-targeted therapy Vyloy, clearing it for gastric and gastroesophageal junction (GEJ) cancer. Vyloy (zolbetuximab) has been given the go-ahead for use in combination with chemotherapy for the first-line treatment of adults with locally advanced or metastatic HER2-negative, claudin 18.2-positive gastric or GEJ adenocarcinoma that cannot be treated with surgery. The European Commission's decision comes a few months after the FDA turned down Astellas' marketing application for zolbetuximab in the US because of "unresolved deficiencies" found during an inspection of a third-party manufacturing facility for the antibody. Astellas refiled its US application in May, and a decision is expected in November. Claudin ...
Read more

ZOOM+Care Brings Mental Health Services to the Seattle Area - NBC Right Now

-
Image
SEATTLE , Nov. 6, 2019 /PRNewswire/ --  ZOOM+Care , a leading provider of on-demand healthcare, is expanding its Mental Health service line to include the Seattle area. Eastside Seattle area residents seeking diagnosis, treatment, and medication management can now schedule a Mental Health visit at ZOOM+Care's Bellevue clinic on NE 8th St in Lincoln Square. In December, the company plans to launch a second Bellevue Clinic, dedicated solely to providing Mental Healthcare specialty services. Located at 10541 NE 4th St, it will be the first ZOOM+Care clinic of its kind. The addition of Mental Healthcare services in Seattle furthers Zoom's mission to provide complete, no-wait care. Previously, Mental Health specialty services were only available to ZOOM+Care patients in Portland.  "For years we've been hoping to bring a more complete service offering to our patients in Seattle , and I'm excited that it's coming to fruition," says Erik Vanderlip , ZOO...
Read more